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A bstract: Arthrospira platensis (Spirulina platensis) is a well-known m icroalga and has been utilized as a 
medicinal agent and foodstuff by humans since at least 16th century. The aim  o f this study was to determine zinc 
content as well as determine phenolic and indole compounds from commercial preparations containing 
Arthrospira platensis (lyophilizate, tablets, and capsules) before and after extraction with m ethanol and incuba­
tion with artificial digestive juices. The secondary aim o f this study was to evaluate the quality o f these prepa­
rations. The samples were incubated in artificial stomach juice and in intestinal juice. The samples were m in­
eralized and their zinc(II) ions content was estimated using flame absorption atomic spectroscopy (F-AAS). The 
maxim um  zinc(II) ions content released into the digestive juices was found to be up to 1.6 m g/100 g o f the 
preparation. Phenolic compounds identified in the examined extracts are as follows: gallic acid; protocatechuic 
acid; 3,4-dihydroxyphenylacetic acid; p-hydroxybenzoic acid; syringic acid; cinnamic acid; and quercetin. 
Furthermore, indole compounds identified were 5-hydroxy-L-tryptophan, 5-methyl-L-tryptophan, L-trypto- 
phan, tryptamine, and 5-methyltryptamine. Consequently, it was also found that the distributed Arthrospira 
platensis in the form of tablets does not disintegrate in the artificial digestive juices. Among the examined 
preparations, only hard capsules m et the requirements of the European Pharm acopeia 8 th ed.
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Arthrospira p la tensis (Spirulina platensis) has 
been used as a food by the A ztecs since the 16th cen­
tury in M exico w hen it w as fished from  Lake 
Texaco and then dried and sold in the form  of b is­
cuits as described by Spanish soldiers. A. p la tensis is 
currently cultivated and is used in m any countries as 
a dietary supplem ent because of its substantial nutri­
tional value (1-3). Arthrospira m axim a  and Arthro- 
spira p la tensis  are the species classified as Spirulina , 
and m ost com m only these species are used in 
dietary supplem ents. The protein content in A. 
p latensis  is approxim ately 65-79%  and is a com ­
plete source of protein and amino acids. A bout 7% 
of the w eight o f A. p la tensis contains lipids, m ainly 
com prising y-linolenic acid, a-lino len ic  acid, stearic 
acid, eicosapentaenoic acid, docosahexaenoic acid, 
and arachidonic acid. A. p la tensis  also contains sig­
nificant amounts o f y-linolenic acid (4, 5). A. platen- 
sis is a good source of w ater-soluble vitam ins such
as C, PP (niacin) from  group B (B1, B2, B 5, B6, and 
B 12); fat-soluble vitam ins, such as A, D, E, and K; 
and eicosapentaenoic acid. It is also a good source of 
macro and m icroelem ents, such as P, Ca, K, Na, M g, 
Fe and also contains inositol and dyes (phyco- 
cyanins, carotenoids, and chlorophyll b) (6, 7, 8). 
Phycocyanin, belonging to the w ater-soluble p ig­
m ents phycobilins (1% of A. p la tensis  mass), is 
m ainly responsible for its ability to neutralize free 
radicals. This blue dye gives A. p la tensis  its charac­
teristic, dark-turquoise color. It also contains caro- 
tenoids such as ß-carotene and ß-cryptoxanthin as 
w ell as chlorophyll a and b. A. p la tensis  is used in 
the prevention and treatm ent o f various diseases 
such as obesity, anemia, hypertension, hyperlipi- 
demia, diabetes, some cancers, neurodegenerative 
diseases such as A lzheim er’s disease, and so on 
(9-13). Due to the antioxidant, anti-inflam m atory, 
antidepressant, and im m unostim ulatory properties
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of A. p la tensis  described earlier in the scientific lit­
erature, it was decided to determ ine its content of 
zinc, phenolic, and indole com pounds (14-16).
Zinc is essential for the proper developm ent of 
hum an body. This elem ent is not only an activator 
bu t is also a cofactor o f about 300 enzymes. Zinc is 
responsible for the m etabolism  of nucleic acids, p ro ­
teins, lipids, and carbohydrates (17). It affects the 
expression of genes during the replication and tran­
scription of DNA and RNA  (17). It is also responsi­
ble for the synthesis o f red  b lood cells and affects 
the functions o f inter alia respiratory, reproductive, 
and im m une system s (18, 19) and also dem onstrates 
an anti-inflam m atory, regenerating and antidepres­
sant activity.
Phenolic and indole com pounds prim arily  
exh ib it an an tiox idant, an ti-in flam m ato ry , and 
im m unostim ulant activity.
The aim  of this study was to perform  quantita­
tive analysis o f zinc ions as well as phenolic and 
indole com pounds in preparations o f com m ercial 
origin containing A. p la tensis  before and after an 
extraction using artificial digestive juices. Flame 
absorption atom ic spectroscopy (F-AAS) was used 
to analyze zinc, w hereas phenolic and indole com ­
pounds w ere determ ined using reverse phase-high 
perform ance liquid chrom atography (RP-HPLC).
The analysis was perform ed to evaluate the 
h ighest am ounts o f b ioelem ents, phenolic, and 
indole com pounds and zinc (II) ions released among 
the preparations containing A. p la tensis (lyophi- 
lizate, tablets, and capsules) after the extraction 
using artificial digestive juices. The final product 
w ill be a better source of these substances for hum an 
consum ption. In addition, the next aim  of the work 
was to evaluate w hether the form ulation containing 
A . p la tensis  is suitable for the effective release of 
zinc and phenolic  and indole com pounds and 
w hether it m eets the pharm acopeia requirem ents.
EXPERIM ENTAL  
R eagents and standards
Standard zinc (II) ions solution at a concentra­
tion of 1000 ppm  was obtained from  OUM  (Łódź, 
Poland); subsequent dilutions of 100, 10, and 1 ppm 
concentrations were prepared from  the above solu­
tion. M gC l2 was obtained from  Chem pur (Kraków, 
Poland); N aCl, KCl, and N aH C O 3 w ere obtained 
from  PPH G olpharm  (Kraków, Poland); pepsin and 
bile salts were obtained from  BTL (Łódź, Poland); 
C aCl2 was obtained from  Pharm a Zentrale GmbH 
(Germ any); pancreatic extract, HCl, KCl, concen­
trated H NO 3 Suprapur®, and K NO 3, Suprapur® were
ob tained  from  M erck (D arm stadt, G erm any); 
C6H8O7, Z nSO 4, K HCO 3, N a2HPO4, K2HPO4, and 
N aO H  were purchased from  Polish Com pany of 
Chem istry (G liwice, Poland). W ater (quadruple-dis­
tilled) w ith the conductivity o f less than 1 pS/cm 
was obtained using an S2-97A 2 distillation appara­
tus (Chem Land, Stargard Szczecin, Poland). The 
follow ing standard phenolic com pounds of HPLC 
grade w ere purchased from  Fluka Chemie Gmbh 
(Sw itzerland): p-coum aric acid; ferulic acid; p- 
hydroxybenzoic acid; vanillic acid; and 3,4-dihy- 
drophenylacetate acid. Caffeic acid, chlorogenic 
acid, cinnam ic acid, o-coum aric acid, protocate- 
chuic acid, sinapic acid, gallic acid, and syringic 
acid and quercetin and standards of indole com ­
pounds, namely, L-tryptophan, 5-hydroxy-L-trypto- 
phan, 6-m ethyl-L-tryptophan, serotonin, m elatonin, 
tryptam ine, and 5-m ethyl-tryptam ine w ere p u r­
chased from  Sigm a-A ldrich (St. Louis, M O , USA); 
all were of HPLC grade. M ethanol, acetic acid, and 
petro leum  ether w ere pu rchased  from  M erck 
(D arm stadt, G erm any) were also o f HPLC grade.
Research material
The studies w ere conducted on the dietary sup­
plem ents containing Arthrospira p la tensis  (m icroal­
gae from  M icrocoleaceae fam ily), two preparations 
in the pow dered form  and two in the tablet form, and 
one in capsules were evaluated. Both, the methano- 
lic extracts o f these preparations and the extracts 
obtained after incubation w ith artificial digestive 
ju ices were objects of the experim ent. The selected 
preparations differed in preparation form  and dosage 
and w ere derived from  d ifferent m anufacturers 
(Table 1).
Preparation of artificial digestive juices
A rtificial saliva (pH = 6.8.) w as prepared 
according to the m ethod o f A rvidson (20). Briefly, 
100 m L KH2PO 4 at a concentration of 25 mm ol/L, 
100 m L N a2HPO4 at a concentration o f 24 mm ol/L, 
100 m L K HCO 3 at a concentration of 150 mm ol/L, 
100 m L M gC l2 at a concentration of 1.5 mm ol/L, 
6 m L citric acid at a concentration of 25 mm ol/L, 
100 m L C aCl2 at a concentration of 15 m m ol/L  were 
added to the flask and the volum e was m ade up to 
1000 m L w ith four-tim es distilled water.
A rtificial stom ach ju ice (pH = 2.0) w as pre­
pared according to the m ethod described in Polish 
Pharm acopeia X. Briefly, 2.0 g N aCl and 3.2 g 
pepsin were dissolved in four-tim es distilled water. 
Then, 80 m L HCl at a concentration of 1 m ol/L was 
added, and the volum e was m ade up to 1 L using 
four-tim es distilled w ater (21).
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A rtificial intestinal juice (pH = 8.0) was p re­
pared according to the m ethod o f N eum ann (22). 
Briefly, 20 mg pancreatic extract, 120 mg bile salt, 
and 8.4 g N aH C O 3 were dissolved in four-tim es d is­
tilled w ater and the volum e w as made up to 1 L 
using four-tim es distilled water.
Sam ple preparation
R elease stud ies w ere perfo rm ed  in  the 
G astroel-2014 apparatus, w hich w as constructed at 
the D epartm ent o f Inorganic and Analytical C hem is­
try at the Faculty o f Pharm acy, M edical College, 
Jagiellonian University. This apparatus allows the 
study of substances released into the artificial d iges­
tive juices, im itates gastrointestinal motions, and 
also provides a constant tem perature of 37OC (23).
P reparations con tain ing  A . p la ten sis  were 
w eighed (at 0.5 g) and after perform ing m ineraliza­
tion three parts of the sam ples w ere m ade: one part 
of the sam ples was used to determ ine zinc (II) ions 
content, the second for m ethanol extraction (pheno­
lic and indole com pounds) while the other part was 
subjected to in vitro digestion using G astroel-2014. 
The second part was used for three tim es extraction 
by 100 m L of m ethanol using ultrasound at a fre­
quency of 49 kH z during 30 m inutes (Sonic-2, 
Polsonic, Poland). For the last part, the w eighed 
sam ple was transferred to 100 m L Erlenm eyer flasks 
and then w etted w ith 2 m L of artificial saliva; sub­
sequently, 100 m L of stom ach juice was added. The 
flasks were closed w ith a stopper and placed in the 
apparatus. The incubation process was continued for 
15, 30, and 60 min. The resulting solutions w ere fil­
tered using a B üchner funnel and a vacuum  set. The 
residue was transferred to Erlenm eyer flasks togeth­
er w ith the filter paper and 100 m L of intestinal juice 
was added (the extraction process lasted 150 min). 
Then, the contents were filtered again. The sam ples 
were divided into two lots, one of w hich was desig­
nated for zinc analysis and the other for the analysis 
of organic com pounds (phenolic and indole com ­
pounds).
Analysis o f Zn content before and after incuba­
tion w ith artificial digestive ju ices using the F- 
AAS method
The concentration of zinc (II) was determ ined 
using the F-AAS method. M ineralization of the 
preparations containing A . p la tensis  w as perform ed 
in the M agnum  II m icrow ave m ineralizer ERTEC 
(Poland). M ineralization was perform ed for 1 h in 
three m agnetron cycles: 15 m in at 60% pow er, 15 
min at 80% pow er, and 30 m in at 100% power. 
M ineralization of solutions after incubation w ith 
artificial digestive ju ices using G astroel-2014 was 
perform ed in the UV R-8 M ineral Poland m ineraliz­
er. This process was perform ed by UV irradiation of 
the m ineralized test solution in a quartz reaction ves­
sel in 5 cycles of 6 -8  h.
Therm o Scientific AA Spectrom eter iCE 3000 
SERIES (USA) was used in all the m easurem ents of 
zinc.
R everse-phase h igh perform ance liquid chro­
matography (R P-H PLC ) o f phenolic com pounds
The extracts obtained from  m ethanol and after 
incubation w ith artificial digestive ju ices were ana­
lyzed for phenolic com pounds using the m ethod of 
RP-HPLC, w hich was perform ed based on the p ro ­
cedure developed by Sulkow ska-Ziaja (24). The 
analysis w as perform ed at 25OC, w ith a mobile 
phase consisting of A -  m ethanol and B -  methanol: 
0.5% acetic acid 1 : 4 (v/v). The follow ing gradient 
was applied: 100% B for 0 -2 0  min; 100-80%  B for 
20-35  min; 80-60%  B for 35-55  min; 60-0%  B for 
55 -70  min; 0% B for 70-75  min; 0 -100%  B for 
75 -80  min; 100% B for 80 -90  m in at a flow  rate 1 
m L/m in, X = 254 nm  (phenolic acids), X = 370 nm 
(flavonoids). Q uantification was perform ed by the 
m easurem ent o f peak area w ith reference to the stan­
dard  curve derived  from  five concentrations 
(0.03125-0.5 m g/mL). The quantitative analysis of 
phenolic com pounds w as perform ed using a calibra­
tion curve w ith the assum ption o f the linear size of 
the area under the peak and the concentration of the
Table 1. Dietary supplements containing Arthrospira platensis which were used for determination o f zinc con­
tent after an extraction to artificial digestive juices.
Name of the preparation Form Expiry date
Spirulina B Powder 11.2016
Spirulina P Powder 07.2012
Spirulina M Capsules 10.2016
Spirulina N Tablets 08.2016
Spirulina O Tablets 03.2017
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reference standard. The results were expressed in 
m g/100 g of dry w eight (d.w.).
R P-H PLC  analysis o f indole com pounds
The extracts obtained from  m ethanol and after 
incubation w ith digestive juices were evaporated to 
dryness under pressure o f 200 m Ba at 40OC (BUchi 
evaporator, G erm any). The concentrated analyte 
w as d isso lved  in m ethanol transferred  through 
W hatm an No. 3 filter paper. The extracts were quan­
titatively dissolved in 1.5 m L of solvent system 
(m ethanol : w ater : am m onium  acetate at 15 : 14 : 1 
v/v/v) and subjected to separation by RP-HPLC 
using the Hitachi HPLC (M erck, Japan) equipped 
w ith a pum p type L-7100, the Purospher® RP-18 (4 
X 200 mm , 5 pm) colum n kept at 25OC and UV 
detector operated at X = 280 nm. The isocratic sepa­
ration was as follows: m ethanol/water/am m onium  
acetate (15 : 14 : 1 v/v/v) at a flow  rate o f 1 mL/min. 
The quantitative analysis of indole com pounds was 
perfo rm ed  using a ca lib ration  curve w ith the 
assum ption of the linear size of the area under the 
peak and the concentration of the reference stan­
dard. Q uantification was perform ed by the m easure­
m ent o f peak area with reference to the standard 
curve derived from  five concentrations (0.0625-1 
mg/m L). The results were expressed in m g/100 g of 
d.w.
Properties o f tablets
The tablets were evaluated as per standard p ro ­
cedure according to European Pharm acopeia 8th ed 
for uniform ity o f weight, hardness, friability, and 
disintegration time (25). Tablets were also tested for 
variation in thickness to determ ine any variability 
associated with the tablet press or the m ethod of 
preparation.
The average w eight was obtained according to 
pharm acopeia lim its by w eighing random ly selected 
20 tab lets on an analy tical balance (O HA US 
A dventurer Pro). The hardness of the tablets was
determ ined for at least 10 tablets using the Erweka 
TBH 20 hardness tester (Erw eka Gm bH ), and adopt­
ing a m inim um  hardness o f 40 N  as the acceptance 
criterion. For each form ula, friability was evaluated 
from the percentage w eight loss of 20 tablets tum ­
b led  in  E rw eka TA R  120 friab ila to r (E rw eka 
Gm bH , H ausenstam m , Germ any) at 25 rpm  for 
4 min. The tablets were dedusted and the loss in 
w eight caused by fracture or abrasion was recorded 
as the percentage w eight loss. Friability < 1% was 
considered acceptable. R espective disintegration 
times o f the prepared tablets were m easured in 900 
m L of purified w ater w ith disks at 37OC using an 
Erweka ZT 222 tester (Erw eka GmbH, H ausen­
stamm, G erm any). Six tablets were random ly select­
ed from each form ulation and were pu t into basket­
rack. The disintegration tim e was recorded till all the 
fragm ents o f the disintegrated tablet passed through 
the screen o f the basket. For non-m odified tablets, 
the disintegration tim e should not be longer than 15 
min. The thickness of the tablets was determ ined for 
20 tablets using digim atic V ernier caliper (0-150 
mm).
Statistical analysis
Statistical analysis o f the data was perform ed 
using one-way A NO VA  w ith Tukey-K ram er post 
hoc analysis o f multiple com parisons. A  value p < 
0.05 was accepted as the level o f statistical signifi­
cance.
RESULTS AND D ISCU SSIO N
This is the first study where the content o f zinc, 
phenolic and indole com pounds in com m ercial 
preparations of A. p la tensis  from  different m anufac­
turers were analyzed. Furtherm ore, the level of these 
com pounds release was investigated using Gastroel- 
2014 apparatus w hich im itates conditions in the 
hum an digestive tract. Selected com m ercially avail­
able preparations as dietary supplem ents differed in
Table 2. Zinc content in selected preparations containing A rthrospira platensis.
Preparation Zinc content in preparations containing spirulina (mg/100 g ± SD)
Spirulina B 1.87 ± 0.05
Spirulina P 0.38 ± 0.02
Spirulina M 0.63 ± 0.03
Spirulina N 1.17 ± 0.06
Spirulina O 1.15 ± 0.07
The data presented was m ean ± SD (standard deviation); n  = 6
Table 3. The content of zinc released to artificial digestive juices from selected Arthrospira platensis  -  containing preparations.
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Digestive
juice Stomach juice Intestinal juice (150 min)
Time
[min] 15 30 60
after 15 in 
stomach juice
after 30 in 
stomach juice
after 60 in 
stomach juice
Amount of Zn released (mg 100 g-1 of preparation)
Spirulina B (powder)
0.60 ± 0.04a 1.56 ± 0.50a 0.33 ± 0.02a 0.14 ± 0.05a 0.14 ± 0.05a 0.39 ± 0.03a
Spirulina P (powder)
0.91 ± 0.07abc 1.14 ± 0.04abcd 0.67 ± 0.04abAd 0.16 ± 0.01bd 0.20 ± 0.00a,c,d 1.05 ± 0.01abAd
Spirulina M (capsules)
0.50 ± 0.17b 0.62 ± 0.04a,b 0.35 ± 0.06a,b 0.24 ± 0.0a,b 0.16 ± 0.02b 0.12 ± 0.00ab
Spirulina N (tablets)
0.26 ± 0.03ab-c 0.27 ± 0.02a,c 0.403 ± 0.08b,c 0.13 ± 0.00bc 0.15 ± 0.02c 0.15 ± 0.00a-b-c
Spirulina O (tablets)
0.21 ± 0.02abd 0.40 ± 0.08cAd 0.22 ± 0.02a,b,c,d 0.27 ± 0.04a-c-d 0.05 ± 0.01abAd 0.09 ± 0.02abAd
Data are presented as the m ean ± standard deviation (SD); n  = 6 repetitions Tukey-K ram er test was used to reveal the differences between 
paired groups o f zinc in rows, the same letters (a, b, c, d, e) are m arked for the content whose differences are statistically significant (for 
p values < 0.05) (GraphPad InStat)
Spirulina  species, p repara tion  form  (pow dered 
lyophilizates, capsules, and tablets), dosage, and 
were derived from  different m anufacturers.
F-AAS was used to evaluate the content o f zinc 
(II) ions in A. p la tensis-con tain ing  preparations that 
were incubated w ith artificial digestive juices. The 
elaborated conditions o f lyophilized m aterial m iner­
alization and the analytical m ethod allow ed to deter­
m ine the zinc(II) ions concentration in preparations 
and extracts o f incubated preparations.
Zinc content in the exam ined preparations was 
found to be in the range of 0.38-1.87 mg/100 g of 
preparation (Table 2). The highest content o f zinc 
(II) ions was determ ined in the pow der form of 
preparation (1.87 mg/100 g of preparation). The 
am ount o f zinc (II) ions released for artificial diges­
tive juice varies w ithin a narrow range of values and 
it depends on the degree of powdering the raw  m ate­
rial in preparations. The content o f zinc (II) ions in 
the dry matter o f A. pla tensis  according to previous 
studies has been reported as 2 mg/100 g (26). But, in 
this study, was found a considerably low er content of 
zinc (II) ions, 0.38 m g/100 g of preparation, in the 
pow dered A. platensis (cell lyophilizate). For tablets, 
very similar amounts were determined, that is, in the 
range of 1.15-1.17 mg/100 g of preparation.
A l-D habi (2013) determ ined zinc (II) ions in A. 
p latensis-con tain ing  preparations and obtained the 
results at a sim ilar level (0 .05-0 .6  m g/100 g of 
preparation) (27).
In order to estim ate the actual quantities o f this 
elem ent available to the hum an body, incubation of 
preparations containing A. p la tensis w ith artificial 
digestive ju ices (in G astroel-2014 apparatus) was 
perform ed under conditions im itating those in the 
hum an body (tem perature 37OC and m ovem ents 
mim icking peristalsis o f the hum an digestive tract). 
O n the basis o f F-AAS analysis was found that zinc 
(II) ions are better released from  lyophilized A. 
platensis  than that from  tablets or capsules. The 
am ount o f zinc (II) ions released into the artificial 
digestive ju ices ranged from  0.05 to 1.56 m g/100 g 
of the preparation (Figs. 1a, b). The highest amount 
of zinc (II) determ ined in artificial stom ach juice 
was in the range of 0.2 to 1.6 mg/100 g o f the prepa­
ration, after 30 m in of incubation (Table 3). In addi­
tion, these am ounts in artificial intestinal juice were 
significantly low er, regardless o f the incubation 
time in the stom ach juice, w hich ranged from  0.1 to
0.4 m g/100 g o f the preparation . The highest 
amounts were determ ined for Spirulina B, that is, 
preparation in the form  of a cell lyophilizate (pow ­
der), and 1.6 m g/100 g of preparation w as released 
into the stom ach juice after 30 m in of incubation 
(Figs. 1a, b). This preparation proved to be the most 
optim al due to the am ount of zinc (II) ions found in 
both types o f artificial digestive ju ices (stom ach and 
intestinal) and in any tim e variant. Zinc (II) ions 
were more efficiently released from  capsules than 
that from  tablets, despite the dem onstrated low er
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content o f this elem ent in the product before incuba­
tion w ith the artificial digestive juices. The degree of 
zinc (II) ions released into the artificial stomach 
ju ice was found to be low est in stom ach juice (in 
case o f 15 m in incubation). The daily  hum an 
dem and for this elem ent is about 12  m g, that is, the 
am ount released from  the preparation can constitute 
zinc supplem ent to the hum an diet (28).
Phenolic and indole com pounds w ere deter­
m ined using R P-H PLC  and the results of the calcu­
lations were converted to the am ount of com pounds 
released from  100 g of the preparation.
Com m ercial preparations of A. p la tensis  are a 
good source of phenolic and indole com pounds. In 
this study, we identified seven phenolic com pounds 
(gallic acid; protocatechuic acid; 3,4-dihydroxy- 
phenylacetic acid; p -hydroxybenzoic acid; syringic 
acid; cinnam ic acid; and quercetin) in alm ost all 
com m ercial preparations (Table 4). Furtherm ore, 
3 ,4-dihydroxy-phenylacetic acid and gallic acid 
w ere found to be highest among the exam ined phe­
nolic compounds. It was best extracted from  the 
pow der form  of preparation released in the artificial 
stom ach juice, w hich was up to 38.1 mg/100 g of 
preparation. In  addition, gallic acid was found to be 
released highest in the intestinal juice from  capsules 
(Spirulina M ) containing lyophilized A. p la tensis , up 
to a m axim um  of 7.3 m g/100 g of preparation. Other 
phenolic com pounds were determ ined in both stom ­
ach and intestinal ju ices at a sim ilar level o f 0.01 to
2.2 m g/100 g of preparation. It is estim ated that 0.1 
to 1.0 g daily dose of phenolic com pounds is 
required in the hum an diet. This range is b road and 
depends largely on the diet, including the am ount of 
consum ed fruits, vegetables, coffee, or tea (29, 30). 
All the analyzed preparations w ere found to be a 
source of phenolic com pounds. A fter conversion of 
the recom m ended daily dosage by m anufacturers for 
the product, the total am ount of phenolic com ­
pounds was determ ined, and on this basis, was 
dem onstrated that the preparations m ay be a source 
of phenolic com pounds up to 60.7 m g/day for 
Spirulina P  (lyophilizate).
The indole com pounds determ ined in the pre­
parations include 5-hydroxy-L-tryptophan, trypta- 
m ine, 5 -m ethyltryptam ine, 6 -m ethyl-tryptophan, 
and L-tryptophan. They were determ ined in a sig­
nificantly low er num ber of experim ental variants 
than phenolic com pounds. Com pared to m ethanolic 
extracts, indole com pounds were determ ined at 
h igher concentrations in artificial digestive juices 
(Table 5). In addition, 5-hydroxy-L-tryptophan was 
indole com pound found in the highest am ounts in 
the digestive juices, up to 156.2 mg/100 g of prepa­
ration . D ue to their num erous health  benefits 
(an tiox idan t, an ti-in flam m atory , antidepressive 
etc.), indole com pounds should be supplemented. 
The daily doses of indole com pounds supplied from 
A. p la tensis  -  containing preparations (converted to 
the doses recom m ended by m anufacturers) were the
Figure 1. a) Total zinc content (mg/100 g o f preparation) after extraction to stomach juice over the time o f 15, 30, and 60 min. b) Total 
zinc content (mg/100 g o f preparation) after extraction to intestinal juice over the time of 15, 30, and 60 m in incubation in stomach juice
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Table 4. The content of phenolic compounds released to artificial digestive juices from selected Arthrospira p/atensis-containing prepara­
tions.
Artificial juice
Artificial stomach juice 
(mg/100 g of preparation)
Artificial intestinal juice 
(mg/100 g of preparation)
^''''UTime [min] 15 30 60 150 150 150
Preparation''''.. (after 1 min incubation in artificial saliva) (after incubation in artificial stomach juice)
Extract to artificial 
digestive juice
Methanolic 
extract (control)
Gallic acid
Spirulina B 0.12 ± 0.05a 0.14 ± 0.00a 0.13 ± 0.00a 0.66 ± 0.00a 0.12 ± 0.00a 0.33 ± 0.00a 0.79 ± 0.02a
Spirulina P 0.18 ± 0.00b 0.38 ± 0.00a,b 0.07 ± 0.2a-b 2.13 ± 0.33b 0.89 ± 0.09b 1.38 ± 0.00a 0.67 ± 0.04b
Spirulina M 0.33 ± 0 .03* 0.69 ± 0 .04* 0.10 ± 0 .01* 7.22 ± 1.11abc 4.56 ± 1.78abc 1.41 ± 0.30ac 2.44 ± 0 .17*
Spirulina N 0.01 ± 0 .0 0 * 0.02 ± 0 .03* 0.01 ± 0.00 0.62 ± 0.58 0.59 ± 0.61 0.42 ± 0.40 1.06 ± 0.06
Spirulina O 0.10 ± 0.00 0.15 ± 0.00 - 7.31 ± 0 .8 1 * 2.32 ± 0.38a-c 2.09 ± 0.74a,d 0.81 ± 0.02c,d
Protocatechuic acid
Spirulina B 1.46 ± 0.14a 0.28 ± 0.05a 1.97 ± 0.05a 0.93 ± 0.10a 0.03 ± 0.00a 0.16 ± 0.06a 0.01 ± 0.001a
Spirulina P 1.44 ± 0.14b 0.01 ± 0.00a,b 0.71 ± 0.05a,b 0.01 ± 0.00a 0.30 ± 0.02b 0.50 ± 0.05a,b 0.01 ± 0.00b
Spirulina M 0.40 ± 0.03a,b,c 0.39 ± 0.05b,c 2.22 ± 0.60b,c 0.04 ± 0.005 0.01 ± 0.001 0.01 ± 0.01 0.01 ± 0.01
Spirulina N 0.20 ± 0.002a,b,d 0.25 ± 0.06b,d 0.64 ± 0.04a-c 0.05 ± 0.001a 0.05 ± 0.003b,c 0.01 ± 0.00a,b 0.05 ± 0.003c
Spirulina O 1.25 ± 0.27c-d 0.79 ± 0 .1 3 * d 0.93 ± 0.0a-c 0.02 ± 0.002a 0.06 ± 0.001* 0.01 ± 0.00a,b 0.01 ± 0.002d
3,4-Dihydroxyphenylacetic acid
Spirulina B 26.47 ± 8.94a 20.27 ± 6.01a 20.90 ± 2.66a 2.05 ± 0.08a 2.29 ± 0.25 4.49 ± 0.20a 1.13 ± 0.11a
Spirulina P 38.14 ± 2.25db 1.83 ± 0.00a 7.05 ± 0.13a-b 2.27 ± 0.19b 2.80 ± 0.30b 9.48 ± 2.11ab 0.71 ± 0.07b
Spirulina M 5.27 ± 0.89a-b 6.55 ± 1.27a 25.15 ± 2.12b-c 3.86 ± 0 .21* 2.39 ± 0.2 1.95 ± 0.04db 1.61 ± 0.13c
Spirulina N 2.05 ± 0.00a,b 3.15 ± 0.77a 7.96 ± 0.24a-c 2.16 ± 0.00c-d 2.00 ± 0.16b 2.14 ± 0.28db 5.77 ± 0.38a,c,d
Spirulina O 6.62 ± 1.30a-b 8.60 ± 1.72a 7.64 ± 1.24ac 3.26 ± 0 .15* 2.23 ± 0.15 1.99 ± 0.34db 0.71 ± 0.01b,c,d
p-Hydroxybenzoic acid
Spirulina B 0.16 ± 0.01a 0.12 ± 0.06a 0.11 ± 0.05a 0.09 ± 0.01a 0.09 ± 0.01a 0.11 ± 0.04a 0.03 ± 0.01a
Spirulina P 0.45 ± 0.07a-b 0.22 ± 0.03b 0.29 ± 002a-b 0.09 ± 0.01b 0.12 ± 0.03 0.22 ± 0.05a,b 0.05 ± 0.01b
Spirulina M 0.11 ± 0.01bc 0.13 ± 0.05c 0.14 ± 0.02b 0.22 ± 0 .03* 0.11 ± 0.03c 0.08 ± 0.00db 0.09 ± 0.01a-bc
Spirulina N 0.09 ± 0.01b-d 0.08 ± 0.00b,d 0.18 ± 0.06 0.34 ± 0 .0 2 * d 0.20 ± 0.19 0.07 ± 0.01b 0.37 ± 0.01a-b-c-d
Spirulina O 0.30 ± 0.04a,b,c,d 0.44 ± 0 .0 1 * d 0.25 ± 0.06a 0.08 ± 0.01c-d 0.10 ± 0.05d 0.09 ± 0.01b 0.05 ± 0.01c-d
Syringic acid
Spirulina B 0.37 ± 0.03a 0.21 ± 0.02a 0.28 ± 0.07a 0.10 ± 0.01a 0.08 ± 0.01a 0.07 ± 0.005a 0.02 ± 0.001a
Spirulina P 0.40 ± 0.02b 0.38 ± 0.02a,b 0.29 ± 0.05b 0.07 ± 0.02b 0.17 ± 0.01a-b 0.21 ± 0.01ab 0.03 ± 0.00ab
Spirulina M 0.04 ± 0.0a-b 0.21 ± 0 .06* 0.45 ± 0 .06* 0.29 ± 0.001* 0.14 ± 0.01a-c 0.05 ± 0.005b,c 0.05 ± 0.01a-bc
Spirulina N 0.02 ± 0.00a-b 0.02 ± 0 .00* 0.05 ± 0 .01* 0.19 ± 0 .0 2 * d 0.09 ± 0 .0 1 * 0.05 ± 0.01bd 0.07 ± 0.01a-b-c-d
Spirulina O 0.04 ± 0.00a-b 0.05 ± 0.0a,b,c 0.05 ± 0.01abc 0.31 ± 0 .0 1 * 0.15 ± 0.03a-d 0.13 ± 0.04db-c-d 0.01 ± 0.00b,c,d
Cinnamic acid
Spirulina B 0.11 ± 0.01a 0.01 ± 0.00a 0.07 ± 0.01a 0.03 ± 0.00a 0.08 ± 0.005a 0.10 ± 0.01a 0.01 ± 0.00a
Spirulina P 0.04 ± 0.005a,b 0.07 ± 0.00 0.05 ± 0.00b 0.11 ± 0.003a-b 0.06 ± 0.01a-b 0.06 ± 0.001a-b 0.01 ± 0.00b
Spirulina M 0.07 ± 0.003* 0.04 ± 0.001c 0.11 ± 0 .02* 0.11 ± 0.01ac 0.07 ± 0.005c 0.07 ± 0.00a,c 0.04 ± 0.002a-b-c
Spirulina N 0.09 ± 0.002* 0.12 ± 0.005dc 0.07 ± 0.00c,d 0.01 ± 0.00a,b,c,d 0.01 ± 0.00a,b,c,d 0.05 ± 0.001a-c-d 0.08 ± 0.005a,b,c,d
Spirulina O 0.04 ± 0.005a,c,d 0.12 ± 0.06a-c 0.03 ± 0.003a,c,d 0.04 ± 0.005* 0.05 ± 0.005a,c,d 0.07 ± 0.00dd 0.02 ± 0 .0 0 * d
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Table 4. Continued.
Artificial juice
Artificial stomach juice 
(mg/100 g of preparation)
Artificial intestinal juice 
(mg/100 g of preparation)
^ ' ' \T im e  [min] 15 30 60 150 150 150
Preparation'''''^^ (after 1 min incubation in artificial saliva) (after incubation in artificial stomach juice)
Extract to artificial
digestive juice
Methanolic 
extract (control)
Quercetin
Spirulina B 0.06 ± 0.01a 0.03 ± 0.00a 0.04 ± 0.00a 0.01 ± 0.00a 0.02 ± 0.00a 0.01 ± 0.00a 0.01 ± 0.00a
Spirulina P 0.04 ± 0.01a-b 0.21 ± 0.02bb 0.11 ± 0.04bb 0.01 ± 0.00b 0.03 ± 0.005a,b 0.18 ± 0.001a-b 0.03 ± 0.00a-b
Spirulina M 0.02 ± 0.00a-b 0.03 ± 0.002b 0.11 ± 0.02a-c 0.02 ± 0.002b-c 0.01 ± 0.00bb 0.01 ± 0.00b 0.03 ± 0.02a-c
Spirulina N 0.01 ± 0.00a-b 0.01 ± 0.00b 0.01 ± 0.00b-c 0.01 ± 0.00c 0.01 ± 0.00bb 0.01 ± 0.00b 0.11 ± 0.00*dd
Spirulina O 0.01 ± 0.00a-b 0.01 ± 0.00b 0.02 ± 0.00b-c 0.01 ± 0.000c 0.01 ± 0.00bb 0.01 ± 0.00b 0.02 ± 0.00*cd
D ata are presented as the m ean ± standard deviation (SD); n  = 6 repetitions Tukey-K ram er test was used to reveal the differences between 
paired groups o f phenolic compounds in rows, the same letters (a, b, c, d) are marked for the content whose differences are statistically sig­
nificant (for p values < 0.05) (GraphPad InStat)
highest for capsules (up to 6.8 mg/day) and the low ­
est for lyophilizate (up to 2.6 mg/day).
In sum m ary, the release of zinc and organic 
com pounds from  preparations containing A. platen- 
sis depended on the tim e of incubation and the 
degree of degradation in artificial digestive juices. 
A rtificial digestive ju ices did not b reak down A. 
p la tensis-containing tablets even after a maximum 
incubation period of 60 min in artificial stomach 
ju ice and 150 min in artificial intestinal juice. 
D uring extractions w as observed the form ation of a 
gelatinous layer on the surface to prevent liquid pen­
etration into the interior and further disintegration of 
the tablet mass. A fter the tablet was cut into two 
parts, the com pletely dry core was clearly visible 
inside.
Thereby, was decided to study the physical 
properties of tablets containing A. p la tensis accord­
ing to European Pharm acopeia 8th ed (25). The phys­
ical properties o f prepared tablets are shown in 
Table 6.
The controlled tablets w ere elegant in appear­
ance. The thickness of the tablets ranged from 4.74 
to 4.99 mm. For form ulation Spirulina O percent 
deviations of thickness exceeded 5% (acceptable 
range of thickness is ±  5%). A verage weight, hard­
ness, and friab ility  w ere w ith in  pharm acopeia  
specification. The variation in w eight ranged from 
255.3 to 401.5 mg (acceptable range of w eight vari­
ation is ±  5%). The hardness o f tablets ranged from 
62.4 to 64.3 N  (acceptable range o f hardness is > 40 
N ) and friability ranged from  0.15 to 0.22%  (accept­
able range of friability is < 1%). The disintegration 
tim es of investigated tablets exceed 15 min. Tablet
form ulations had excessively long disintegration 
times w hich am ounted from  72.3 to 81.2 min. The 
average disintegration tim e of investigated tablets 
was found to be up to 76.7 min. A ccording to 
European Pharm acopeia 8th ed., the disintegration 
times for these preparations should be less than 15 
min. Hence, on the basis o f the conducted studies, 
was found that A. p la tensis  in the form of tablets 
cannot be a good source of zinc and organic com ­
pounds in the hum an diet. O f the three preparations 
containing A. p la tensis tested in accordance with the 
pharm acopeia regulations, only capsule form com ­
plied with the pharm acopeia standards. The devia­
tions o f w eight in capsule ranged from 0.2 to 3.6% 
and the disintegration tim e was found to be 11.5 
min.
C hem om etric analysis
Chem om etric tools w ere used to obtain deeper 
inform ation o f the obtained dataset (results o f indo­
le and phenolic com pounds perform ed for prepara­
tions containing A. p la tensis). The analysis was 
based on Table 4. and 5. The objects o f analysis 
w ere preparations containing A. p la tensis in various 
form s (powder, tablets, and capsules), described by 
param eters -  analyzed indole and phenolic com ­
pounds. Chem om etric analysis for such a dataset, 
characterized by a wide range o f variability, allowed 
the extraction of additional inform ation on the cor­
relations that occur betw een the analyzed objects 
preparations containing A. p la tensis . Two methods 
for chem om etric analysis were used in the study: 
c luster analysis (CA) and principal com ponent 
analysis (PCA). CA m ethod indicated the sim ilarity
Table 5. The content of indole compounds released to artificial digestive juices from selected Arthrospira platensis -  containing preparations.
Release o f bioactive substances from formulations containing... 1195
Artificial juice
Artificial stomach juice 
(mg/100 g of preparation)
Artificial intestinal juice 
(mg/100 g of preparation)
* \ T i m e  [min] 15 30 60 150 150 150
Preparation (after 1 min incubation in artificial saliva) (after incubation in artificial stomach juice)
Control
5-Hydroxy-L-tryptophan
Extract Control
Spirulina B 124.14 ± 10.3d 18.10 ± 0.81* 88.73 ± 12.0- 45.74 ± 1.79‘ 35.56 ± 4.21‘ 50.02 ± 8.78- 11.47 ± 0.71‘
Spirulina P 117.35 ± 2.41d-b - 25.02 ± 1.21ab 33.81 ± 5.67b 29.07 ± 4.31b 21.25 ± 1.41ab 9.54 ± 0.15b
Spirulina M 27.17 ± 2.98db 80.28 ± 1.60* - 156.20 ± 17.2b 96.69 ± 11.06-1c 28.70 ± 1.71a -
Spirulina N 22.07 ± 1.93ab 3.47 ± 0 .04* 46.46 ± 3 .96* 1 33.02 ± 3.97c 60.51 ± 5.84* 23.39 ± 1.18‘ 29.49 ± 1.61dbd
Spirulina O 27.19 ± 1.02ab 42.23 ± 3 .6 2 * 27.71 ± 2.43"a 42.03 ± 2.24c 34.56 ± 3.43°-d 33.29 ± 2.92a,b -
Tryptamine
Extract Control
Spirulina B - - - 1.54 ± 0.00- 1.57 ± 0.01- 5.37 ± 0.80a -
Spirulina P 1.66 ± 0.01 - - 1.57 ± 0.00b 1.83 ± 0.03b 1.71 ± 0.20‘-b -
Spirulina M - 2.37 ± 0.00 - 3.66 ± 0 .38* 2.94 ± 0.38d-bb 4.23 ± 0.17dAd -
Spirulina N - 1.68 ± 0.15 1.36 ± 0.01 - - - -
Spirulina O - - - 3.18 ± 0 .0 8 * d 2.37 ± 0.37‘-d 2.49 ± 0 .09* -
5-Methyltryptamine
Extract Control
Spirulina B - - 3.27 ± 0.00 3.43 ± 0.01 3.21 ± 0.01 3.21 ± 0.01 0.69 ± 0.01
Spirulina P - - - - - - -
Spirulina M - - - - - - -
Spirulina N - - - - - - -
Spirulina O - - - - - - -
6-Methyl-L-tryptophan
Extract Control
Spirulina B 1.57 ± 0.08" 1.03 ± 0.00- 1.40 ± 0.10- 1.12 ± 0.01 0.92 ± 0.08- - -
Spirulina P 3.71 ± 0.18ab 3.92 ± 0.21‘-b 1.41 ± 0.22b 1.92 ± 0.33d-b 2.94 ± 0.11bb 5.00 ± 0.26‘-b 0.76 ± 0.04b
Spirulina M 3.06 ± 0 .21* 10.23 ± 1.74* 4.91 ± 0.08‘-b - - 1.04 ± 0.01d-bb -
Spirulina N 2.44 ± 0 .1 1 * d - - 0.26 ± 0.01bb 0.74 ± 0.09b,c,d - 1.38 ± 0.01b
Spirulina O 1.00 ± 0 .0 8 * d 1.88 ± 0.83c 1.13 ± 0.20°-d - 0.74 ± 0.04a,b,d 0.58 ± 0.04bbbd -
L-Tryptophan
Extract Control
Spirulina B 2.39 ± 0.78- 27.7 ± 0.32 1.69 ± 0.42 1.50 ± 0.10 0.50 ± 0.01 - -
Spirulina P 2.61 ± 0.25b 12.03 ± 0.46‘-b 0.46 ± 0.00d-b - - - -
Spirulina M 9.60 ± 0 .78* 18.45 ± 1.75* 1.26 ± 0 .05* 2.92 ± 0.00 1.08 ± 0.10 - -
Spirulina N 0.76 ± 0 .06* - 0.83 ± 0 .04* - - - -
Spirulina O - 1.09 ± 0.40bb 0.75 ± 0 .03* - - - -
Data are presented as the m ean ± standard deviation (SD); n  = 6 repetitions Tukey-K ram er test was used to reveal the differences between 
paired groups o f phenolic compounds in rows, the same letters (a, b, c, d) are marked for the content whose differences are statistically sig­
nificant (for p values < 0.05) (GraphPad InStat)
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betw een the exam ined objects (preparations contain­
ing A. platensis). In case of this analysis, the sim i­
larity o f objects is dem onstrated by their close rela­
tive position in m ultidim ensional space. The graph­
ical im age of the C A  analysis is the dendrogram  
(Fig. 2), in w hich the objects characterized by con­
siderab le  sim ilarity  form  the clusters. In this 
instance, the x  and у -axes do not correspond to the 
C artesian num erical axes (31, 32). The analyzed 
objects (A. pla tensis  preparations) w ere m arked on 
the x -axis, w hereas the distance betw een the exam ­
ined objects calculated on the basis o f W ard ’s 
agglom eration m ethod on the у -axis. Three major 
clusters w ere observed based on the sim ilarity 
analysis (CA -  Fig. 2). The first cluster formed 
preparations in the form  of capsules, while the 
rem aining clusters were form ed from  preparations in
the form  of tablets or pow ders. Their m em bership in 
particular clusters indicates their sim ilarity w ithin 
particular clusters. This sim ilarity m ay be related to 
the com position of the exam ined preparations (con­
tent o f indole and phenolic com pounds) as w ell as 
the degree of release o f the exam ined metabolites 
into the digestive juices.
Short dendrogram  arm s in case of preparations 
in the form  of tablets show the highest correlation 
sim ilarity w ithin these preparations (31, 33). In 
addition, the differences betw een the preparations 
(capsules and tablets and pow dered form) belonging 
to other clusters m ay result from  unequal conditions 
of A. p la tensis  culture and depend on the type o f A. 
platensis  used in the preparations; therefore, there 
are discrepancies for m etabolites released into the 
digestive juices.
Figure 2. Dendrogram presenting similarity between the objects (preparations containing Arthrospira platensis) depending on the form of 
preparation (City-Block, W ard’s algorithm). The analysis was performed in Statgraphics Centurion XVII program
Figure 3. Scatterplot -  similarity o f the analyzed preparation with Arthrospira platensis w ith respect to the site of release phenolic and 
indole compounds (s. j -  stomach juice, i. j -  intestinal juice). The analysis was performed in Statgraphics Centurion XVII program
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Figure 4. Biplot diagram presenting the correlation between the analyzed organic compound present in the preparations containing 
Arthrospira platensis  and the site of their release in hum an digestive tract (s. j -  stomach juice, i. j -  intestinal juice). The analysis was per­
formed in Statgraphics Centurion XVII program
Table 6. Evaluation of physical properties of prepared tablets (m ean ± standard deviation).
Formulation Weight variation 
(mg)
Thickness
(mm)
Friability
(%)
Breaking force 
(N)
Disintegration time 
(min)
Spirulina M 443.0 ± 4.62 7.5 ± 1.10 - - - 11.5 ± 1.05
Spirulina N 401.45 ± 4.21 4.74 ± 0.03 0.219 62.4 ± 7.06 81.17 ± 5.56
Spirulina O 255.3 ± 5.09 4.99 ± 0.12 0.15 64.3 ± 6.38 72.33 ± 4.59
Table 7. Factor loads for three first m ain principal components (PC1, PC2, and PC3).
Compounds PC1 PC2 PC3
3,4-Dihydroxyphenylacetic acid 0.450 0.217 -0.170
5-Hydroxy-L-tryptophan 0.061 0.581 -0.090
6-methyl-D,L-Tryptophan 0.314 -0.070 0.415
Cinnamic acid -0.038 0.226 -0.173
Gallic acid -0.242 0.495 0.249
L-Tryptophan 0.186 -0.137 0.528
p-Hydroxybenzoic acid 0.279 0.047 -0.277
Protocatechuic acid 0.422 0.084 -0.355
Quercetin 0.326 -0.061 0.333
Syringic acid 0.381 0.352 0.240
Tryptamine -0.303 0.397 0.216
The second m ethod com plem entary to the CA 
used in this study is PCA. PC A  allows the reduction 
of the m easurem ent data space to the m inim um  nec­
essary to characterize the interactions betw een them. 
A  large num ber of param eters (m easured content of 
indole and phenolic com pounds) describing ana­
lyzed objects (preparations w ith A. p la tensis) made 
the direct visualization of m ultidim ensional data 
space com plicated. In order to facilitate it, the num ­
ber of data was reduced by correlating them. Output 
param eters were replaced by new  variables -  p ri­
m ary com ponents. PC A  analysis dem onstrated that
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61.92% of the variations in the exam ined data set can 
be described by the three prim ary components (PC1, 
PC2, and PC3). Consequently, the rem aining com po­
nents were not considered for further analysis. The 
three prim ary components (PC1, PC2, and PC3) are a 
linear combination of prim ary variables m ultiplied by 
corresponding charges. The values of the charges that 
correspond to the correlation coefficient with the pri­
m ary variables are sum marized in Table 7. For the 
PC1 component, its magnitude is considerably affect­
ed by the m easured value ofthe phenolic compound, 
that is, 3,4-dihydroxyphenylacetic acid. The other 
main components, PC2 and PC3, can be interpreted in 
the same way. Consequently, the reduction of the 
input data area to the three prim ary components 
allowed for analysis in two-dimensional space (Fig. 
3) (34, 35). Two distinct clusters were distinguished 
analyzing the exam ined objects (preparations with A. 
platensis) in relation to the site in the digestive sys­
tem, where phenolic and indole compounds were 
released (Fig. 3). These compounds are to a various 
degree released into an artificial stomach and intes­
tinal juices, as evidenced by their belonging to dis­
tinct groups. Such division indicates that the exam i­
ned organic components are released into the diges­
tive juices to varying degrees, which in turn, depends 
on the release site in the condition im itated human 
digestive tract. In addition, considering the Biplot dia­
gram (Fig. 4) based on the two prim ary components 
(PC1 and PC3), the preference of components to the 
site where they were released into the artificial diges­
tive tract was analyzed. On this basis, was found that 
the release of indole and phenolic compounds from 
preparations containing A. platensis into artificial 
digestive juices depended on the type of artificial 
digestive juice. The organic compounds from the 
preparations were to the highest degree released into 
stomach juices, which confirms the direction of the 
arms in the B iplot diagram (Fig. 4). Only sparse phe­
nolic compounds (gallic acid and cinnamic acid) and 
indole ones (tryptamine) were released from the 
preparations mostly to intestinal juice.
C O N CLUSIO N S
The experim ent p resented  that the active sub­
stances in the com m ercial preparations are not com ­
pletely released  into the artificial digestive ju ices 
and hence m ay not be potentially  available to 
hum an. The quantities o f released zinc (II) ions 
from  preparations containing A. p la tensis  are insuf­
ficient for hum an body according to the daily 
requirem ent for this elem ent. In the case o f pheno­
lic com pounds, their am ounts w ere found to be
higher in the extracts o f artificial digestive ju ices 
than that o f m ethanolic extracts o f the tested prepa­
rations. In this way, it has been adequately shown 
that the content o f active substance in m edicinal 
preparations is not the same as its am ount released 
into digestive ju ices w hich suggest the need for 
such analyzes. The experim ent further show ed that 
only hard capsules m et the European Pharm acopeia 
8th ed standards w hereas tablets did not. D ue to this 
fact, an im portant elem ent o f research on dietary 
supplem ents is the evaluation of their form ulations’ 
quality and the definition o f a form  that allows the 
release o f biologically  active com pounds in the 
m ost effective manner.
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